UNAIDS welcomes US approval of drug to stop HIV

July 17, 2012

The UN agency tasked with fighting AIDS on Tuesday welcomed the decision by the United States to allow the use of an HIV prevention pill for the first time.

The pill will be used "to prevent the sexual transmission of HIV for people who do not have HIV, but who are at high risk of being exposed to the virus", UNAIDS said in a statement from its Geneva headquarters.

Since 2004, the combination of drugs contained in the pill -- and tenofovir disoproxil fumarate -- has been used to help those with HIV, but not to protect against infection, the agency said.

The (FDA) approved the pill -- known as Truvada -- on Monday based on results from clinical trials which found that a daily oral dose of tenofovir, or emtricitabine/tenofovir disoproxil fumarate, carried significant preventative benefits, UNAIDS said.

HIV prevention of this kind is called pre-exposure prophylaxis, or PrEP, which the FDA approved as part of a wider HIV prevention strategy that includes and other safer sex practices, risk reduction counselling and control of other sexually transmitted infections.

Explore further: Pivotal study in Africa finds that HIV medications prevent HIV infection

Related Stories

AIDS: HIV drugs boost prevention hopes

July 13, 2011

Heterosexuals who take daily AIDS drugs reduce the risk of being infected by the human immunodeficiency virus (HIV) by nearly two-thirds, ground-breaking studies said on Wednesday.

NIH modifies 'VOICE' HIV prevention study in women

September 28, 2011

A large-scale clinical trial evaluating whether daily use of an oral tablet or vaginal gel containing antiretroviral drugs can prevent HIV infection in women is being modified because an interim review found that the study ...

Recommended for you

Study reveals how HIV enters cell nucleus

June 21, 2016

Loyola University Chicago scientists have solved a mystery that has long baffled HIV researchers: How does HIV manage to enter the nucleus of immune system cells?

Study observes potential breakthrough in treatment of HIV

June 17, 2016

A new study conducted by researchers at the San Francisco VA Medical Center (SFVAMC) observes that pharmacological enhancement of the immune systems of HIV patients could help eliminate infected cells, providing an important ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.